Rebound Anticipated For Malaysia Stock Market

The Malaysia stock market on Friday halted the three-day winning streak in which it had gained almost a dozen points or 0.7 percent. The Kuala Lumpur Composite Index now rests just shy of the 1,620-point plateau although it\'s likely to bounce higher again on Monday. The global forecast for the Asian markets is positive, with...

Read More

Higher Open Anticipated For Hong Kong Shares

The Hong Kong stock market has moved higher in consecutive trading days, rallying more than 800 points or 4.5 percent along the way. The Hang Seng Index now rests just above the 18,290-point plateau and it\'s got a positive lead again for Monday\'s trade. The global forecast for the Asian markets is positive, with bargain...

Read More

European Shares Subdued On Chinese Demand Concerns

European stocks were subdued on Monday after three straight sessions of gains. A cautious undertone prevailed as an attempt on former U.S. President Donald Trump\'s life injected fresh uncertainty into an already tumultuous presidential campaign. On the positive side, Eurostat data showed industrial production in the euro area fell less than expected in May. Seasonally...

Read More

Beam Therapeutics CFO Terry-Ann Burrell To Resign

Biotechnology company Beam Therapeutics Inc. (BEAM) announced Monday that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024 to pursue a new opportunity as vice chairman of investment banking at JPMorgan Chase. She served as CFO since August 2019. As part of a transition process, the company has initiated...

Read More

Lupin Divests U.S. Commercial Women\'s Health Specialty Business To Evofem Biosciences

Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women\'s Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women\'s Health. Lupin\'s U.S. Commercial Women\'s Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules. This FDA-approved single-dose antimicrobial agent provides a...

Read More